         DISEASE PREVENTION AND SUBSTANCE ABUSE      REDUCTION AMENDMENTS           GENERAL SESSION      STATE OF UTAH      Chief Sponsor   Steve Eliason      Senate Sponsor    Brian E. Shiozawa             LONG TITLE      General Description             This bill amends the Utah Health Code.       Highlighted Provisions             This bill                   authorizes the operation of syringe exchange programs in the state                   specifies the requirements a syringe exchange program must meet                   requires the department to report to the Legislature every two years on the activities       and outcomes of syringe programs operating in the state  and                  requires rulemaking by the department.       Money Appropriated in this Bill             None       Other Special Clauses             None       Utah Code Sections Affected        ENACTS                   , Utah Code Annotated                    Be it enacted by the Legislature of the state of Utah             Section  .  Section        is enacted to read                   . Syringe exchange and education.                 The following may operate a syringe exchange program in the state to prevent the       transmission of disease and reduce morbidity and mortality among individuals who inject       drugs, and those individuals  contacts              a   a government entity, including              i   the department              ii   a local health department, as defined in Section   A                    iii   the Division of Substance Abuse and Mental Health within the Department of       Human Services  or             iv   a local substance abuse authority, as defined in Section   A                     b   a nongovernment entity, including              i   a nonprofit organization  or             ii   a for profit organization  or             c   any other entity that complies with Subsections     and    .                 An entity operating a syringe exchange program in the state shall              a   facilitate the exchange of an individual s used syringe for one or more new syringes       in sealed sterile packages              b   ensure that a recipient of a new syringe is given verbal and written instruction on              i   methods for preventing the transmission of blood borne diseases, including hepatitis       C and human immunodeficiency virus  and             ii   options for obtaining              A   services for the treatment of a substance use disorder              B   testing for a blood borne disease  and             C   an opiate antagonist under Chapter   , Emergency Administration of Opiate       Antagonist Act  and             c   report annually to the department the following information about the program s       activities              i   the number of individuals who have exchanged syringes              ii   the number of used syringes exchanged for new syringes  and             iii   the number of new syringes provided in exchange for used syringes.                 No later than October  ,     , and every two years thereafter, the department shall       report to the Legislature s Health and Human Services Interim Committee on              a   the activities and outcomes of syringe programs operating in the state, including              i   the number of individuals who have exchanged syringes              ii   the number of used syringes exchanged for new syringes              iii   the number of new syringes provided in exchange for used syringes              iv   the impact of the programs on blood borne infection rates  and             v   the impact of the programs on the number of individuals receiving treatment for a       substance use disorder              b   the potential for additional reductions in the number of syringes contaminated with       blood borne disease if the programs receive additional funding              c   the potential for additional reductions in state and local government spending if the       programs receive additional funding              d   whether the programs promote illicit use of drugs  and             e   whether the programs should be continued, continued with modifications, or       terminated.                 The department shall make rules, in accordance with Title   G, Chapter  , Utah       Administrative Rulemaking Act, specifying how and when an entity operating a syringe       exchange program shall make the report required by Subsection     c .Legislative Review NoteOffice of Legislative Research and General Counsel  